Medicure, Inc. (NASDAQ:MCUJF) | WebDisclosure

Basculer en Français

10177	Companies
209286	Keywords
139391	Articles
110940	Press releases

Home
Companies
Medicure, Inc.

PRESS RELEASE

published on 06/24/2024 at 23:00, 1 year 9 months ago

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use

Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use
BRIEF

published on 05/28/2024 at 23:05, 1 year 10 months ago

Medicure Reports Financial Results for Q1 2024 and Director Election Results

Financial Results Director Election Q1 2024 Medicure
BRIEF

published on 05/28/2024 at 23:05, 1 year 10 months ago

Medicure publie ses résultats financiers pour le premier trimestre 2024 et les résultats de l'élection des administrateurs

Résultats Financiers Médicament T1 2024 Élection Du Directeur
PRESS RELEASE

published on 05/28/2024 at 23:00, 1 year 10 months ago

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed

Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
BRIEF

published on 04/23/2024 at 23:05, 1 year 11 months ago

Medicure reçoit la désignation Fast Track de la FDA pour le traitement MC-1 du déficit en PNPO

Medicure Inc. Désignation De Médicament Orphelin Désignation Fast Track De La FDA MC-1 Carence En PNPO
BRIEF

published on 04/23/2024 at 23:05, 1 year 11 months ago

Medicure Receives FDA Fast Track Designation for MC-1 Treatment for PNPO Deficiency

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency
PRESS RELEASE

published on 04/23/2024 at 23:00, 1 year 11 months ago

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRIEF

published on 04/08/2024 at 23:05, 1 year 11 months ago

Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre

Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
BRIEF

published on 04/08/2024 at 23:05, 1 year 11 months ago

Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance

Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 04/08/2024 at 23:00, 1 year 11 months ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed

Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis

Accesswire

Published on 04/08/2026 at 18:45, 15 minutes ago

Nano One to Receive Additional C$4.3M from the Government of Canada to Advance Battery Material Production for Energy Security & Defence
Published on 04/08/2026 at 18:45, 15 minutes ago

Nano One recevra 4,3 M$ supplémentaires du gouvernement du Canada pour faire avancer la production de matériaux de batterie pour la sécurité énergétique et la défense
Published on 04/08/2026 at 16:08, 2 hours 52 minutes ago

Super Copper Announces Investor Relations Agreement
Published on 04/08/2026 at 14:30, 4 hours 30 minutes ago

Goldcliff Confirms Free Gold at Kettle Valley North Cliff Zone, Assays up to 2.70 g/t Au and 29.2 g/t Ag
Published on 04/08/2026 at 14:30, 4 hours 30 minutes ago

Datametrex Enters Strategic Agreement with Hilco Global to Advance Patent Monetization

View all ACCESSWIRE

EQS Group

Published on 04/08/2026 at 18:10, 50 minutes ago

PolyPeptide announces results of the annual General Meeting 2026
Published on 04/08/2026 at 18:05, 55 minutes ago

lePERMISLIBRE publie ses résultats annuels 2025
Published on 04/08/2026 at 18:00, 59 minutes ago

The General Meeting of Shareholders of Zug Estates Holding Ltd approves all proposals by the Board of Directors
Published on 04/08/2026 at 17:45, 1 hour 14 minutes ago

FIGEAC AÉRO: FIGEAC AÉRO PUBLIE LE NOUVEAU NUMÉRO DE ONBOARD, LA LETTRE AUX ACTIONNAIRES DU GROUPE
Published on 04/08/2026 at 17:40, 1 hour 19 minutes ago

Long Term Incentive Plan (“LTIP”) Award

Les Echos

Published on 04/08/2026 at 18:17, 42 minutes ago

Mise à disposition du Rapport sur la solvabilité et la situation financière 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:16, 43 minutes ago

Mise à disposition des états financiers 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:02, 58 minutes ago

Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 18:02, 58 minutes ago

Mise à disposition du Document d'Enregistrement Universel 2025
Published on 04/08/2026 at 17:45, 1 hour 15 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE